Convalescent plasma offers little benefit in treating COVID-19
From www.futurity.org
2021-08-26 15:23:35
Stanford
Excerpt:
A new paper details how convalescent plasma, once considered a promising way to treat people with mild to moderate COVID-19, did not prove effective.
In February, the National Institutes of Health terminated an ambitious clinical trial to study the effectiveness of COVID-19 convalescent plasma because the treatment showed little benefit in an interim analysis.
COVID-19 convalescent plasma refers to blood plasma derived from patients who have recovered from COVID-19 and, as a result, have developed antibodies. Although forms of convalescent plasma therapy have been used as therapy for other infections since the early 1900s, few…